Clinical Trial Update: Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III trial update for concurrent chemoradiotherapy with or without JP001 in newly diagnosed glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• JP001

Snippet

Sponsor: Johnpro Biotech, Inc. | Conditions: Glioblastoma | Phase 2, Phase 3 | Status: UNKNOWN